BioCentury
ARTICLE | Clinical News

Alexion preclinical data

November 1, 1999 8:00 AM UTC

ALXN researchers and colleagues presented data from monkeys in which 5G1.1 increased the acceptance of transplanted fetal pig dopaminergic neurons. 5G1.1 is in Phase II testing to treat rheumatoid arthritis and membranous nephritis. Data were presented at the Society for Neuroscience meeting in Miami Beach. ...